BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Oct 25, 2010
 |  BC Week In Review  |  Company News  |  Other News

Knopp Neurosciences neurology news

Knopp Neurosciences transferred all assets, excluding dexpramipexole (KNS-760704), to new parent entity, Knopp Biosciences LLC, which will focus on expanding its drug discovery capabilities, including research activities directed at mitochondrial mechanisms...

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >